Follow The Short Interest: Could Aoxing Pharmaceutical Company Incorporated (NYSEMKT:AXN) Skyrocket? The Stock Had Too Little Sellers

November 25, 2016 - By Richard Conner   ·   0 Comments

Follow The Short Interest: Could Aoxing Pharmaceutical Company Incorporated (NYSEMKT:AXN) Skyrocket? The Stock Had Too Little Sellers

The stock of Aoxing Pharmaceutical Company Incorporated (NYSEMKT:AXN) registered a decrease of 57.98% in short interest. AXN’s total short interest was 29,500 shares in November as published by FINRA. Its down 57.98% from 70,200 shares, reported previously. With 104,800 shares average volume, it will take short sellers 0 days to cover their AXN’s short positions. The short interest to Aoxing Pharmaceutical Company Incorporated’s float is 0.06%. The stock increased 2.71% or $0.011 on November 23, hitting $0.41. Aoxing Pharmaceutical Company Inc (NYSEMKT:AXN) has declined 48.00% since April 22, 2016 and is downtrending. It has underperformed by 53.41% the S&P500.

Aoxing Pharmaceutical Company, Inc. is a specialty pharmaceutical firm specializing in research, development, manufacturing and distribution of a range of narcotic, pain-management and addiction treatment pharmaceutical products. The company has a market cap of $30.53 million. The Firm holds approximately 140 drug production certificates covering narcotic pain-management, prescription medicines, over-the-counter and active pharmaceutical ingredient (API) products. It has a 25.43 P/E ratio.

AXN Company Profile

Aoxing Pharmaceutical Company, Inc., incorporated on January 24, 1996, is a specialty pharmaceutical firm specializing in research, development, manufacturing and distribution of a range of narcotic, pain-management and addiction treatment pharmaceutical products. The Firm holds approximately 140 drug production certificates covering narcotic pain-management, prescription medicines, over-the-counter (OTC) and active pharmaceutical ingredient (API) products. The Company’s products include prescription drugs, such as Tilidine hydrochloride, Zhongtong’an and Humifuse Euphorbia Herb Tablet, and OTC drugs, such as Shanmei Capsule, Shaoshang Tincture, Yiqi Qiangshen Granule, Xiaopiling Granule, Xiongjushangqing Tablet, Juyuansuanbijia Oral Solutions, Longdanxiegan Tablet, Fenka Tablet, Shujinhuoxue Tablet, Fuketiaojing Tablet, Qingnao Jiangya Tablet, Yuanhu Pain Management Tablet, Bushenqiangshen Tablet, Baiziyangxin Pill, Qingguo Pill, Liuweidihuang Pill, Zhibaidihuang Pill, Xiaoyao Pill and Tianwangbuxin Pill.

More notable recent Aoxing Pharmaceutical Company Inc (NYSEMKT:AXN) news were published by: Seekingalpha.com which released: “Figuring Out Aoxing Pharmaceutical’s Future” on December 29, 2015, also Benzinga.com with their article: “Aoxing Pharmaceutical Starts producing Tilidine Hydrochloride Tablets” published on June 30, 2016, Thestreet.com published: “Aoxing Pharmaceutical (AXN) Stock Plummeting to Reverse Yesterday’s Gains” on June 10, 2015. More interesting news about Aoxing Pharmaceutical Company Inc (NYSEMKT:AXN) were released by: Prnewswire.com and their article: “Aoxing Pharma Appoints Dr. James Chen as Chief Financial Officer” published on February 01, 2016 as well as Thestreet.com‘s news article titled: “Aoxing Pharmaceutical (AXN) Stock Spikes After Announcing Full Year Net Income” with publication date: October 13, 2015.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Richard Conner


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>